Recent evidence suggests that ALDH1 or ALDH3A1, which may be lung tumor stem cell markers or therapeutic targets, are highly expressed in some NSCLC cell lines as well as in patient lung cancer samples [21, 22]. Here, ALDH1A1 is linked to lung carcinoma.